Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(10):687; doi:10.1093/jnci/djn165
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

18F-FDG PET to Detect Cervical Node Metastases in HNSCC

Diagnosing lymph node metastases of patients with head and neck squamous cell carcinoma (HNSCC) is especially critical to make treatment decisions for patients who have been clinically diagnosed as cervical lymph node negative (cN0). Positron emission tomography with 18F-fluorodeoxyglucose (18F-FDG PET) is a method that has been proposed to improve diagnosis of these metastases. To determine how well 18F-FDG PET performs as a diagnostic tool in this situation and how it compares with other diagnostic methods, Kyzas et al. (p. 712) performed a meta-analysis of 32 studies that included 1236 patients. Across all patients, sensitivity of 18. . . [Full Text of this Article]

Design of Clinical Trials in Hepatocellular Carcinoma

The Risk Over Time to Sisters of Women with Breast Cancer

Physical Activity and Risk of Premenopausal Breast Cancer

Treatment Disparities After Referral for Rectal Cancer

Endoscopic Sphincterotomy and Risk of Cholangiocarcinoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Endoscopic Sphincterotomy and Long-Term Risk of Cholangiocarcinoma: A Population-Based Follow-up Study
Frank Viborg Mortensen, Peter Jepsen, Robert E. Tarone, Peter Funch-Jensen, Lone S. Jensen, and Henrik Toft Sørensen
J Natl Cancer Inst 2008 100: 745-750. [Abstract] [Full Text] [PDF]

18F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis
Panayiotis A. Kyzas, Evangelos Evangelou, Despina Denaxa-Kyza, and John P. A. Ioannidis
J Natl Cancer Inst 2008 100: 712-720. [Abstract] [Full Text] [PDF]

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Josep M. Llovet, Adrian M. Di Bisceglie, Jordi Bruix, Barnett S. Kramer, Riccardo Lencioni, Andrew X. Zhu, Morris Sherman, Myron Schwartz, Michael Lotze, Jayant Talwalkar, Gregory J. Gores, and for the Panel of Experts in HCC-Design Clinical Trials
J Natl Cancer Inst 2008 100: 698-711. [Abstract] [Full Text] [PDF]

A Prospective Study of Age-Specific Physical Activity and Premenopausal Breast Cancer
Sonia S. Maruti, Walter C. Willett, Diane Feskanich, Bernard Rosner, and Graham A. Colditz
J Natl Cancer Inst 2008 100: 728-737. [Abstract] [Full Text] [PDF]

Residual Treatment Disparities After Oncology Referral for Rectal Cancer
Arden M. Morris, Kevin G. Billingsley, Awori J. Hayanga, Barbara Matthews, Laura-Mae Baldwin, and John D. Birkmeyer
J Natl Cancer Inst 2008 100: 738-744. [Abstract] [Full Text] [PDF]

Timing of Familial Breast Cancer in Sisters
Paola Rebora, Kamila Czene, and Marie Reilly
J Natl Cancer Inst 2008 100: 721-727. [Abstract] [Full Text] [PDF]

FDG-PET Staging of Head and Neck Cancer—Can Improved Imaging Lead to Improved Treatment?
David L. Schwartz, Homer A. Macapinlac, and Randal S. Weber
J Natl Cancer Inst 2008 100: 688-689. [Extract] [Full Text] [PDF]